会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method of identifying and treating invasive carcinomas
    • 识别和治疗侵袭性癌的方法
    • US06689614B1
    • 2004-02-10
    • US10369032
    • 2003-02-18
    • Karl X. ChaiLi-Mei ChenLee ChaoJulie Chao
    • Karl X. ChaiLi-Mei ChenLee ChaoJulie Chao
    • G01N3350
    • G01N33/574C12Q1/6886C12Q2600/154C12Q2600/158
    • Prostasin protein has been found to be a useful marker for determination of the invasiveness of and as a means to treat human carcinomas. Using RT-PCR and western blot analyses, prostasin protein and mRNA expression were found in normal human prostate epithelial cells and the human prostate cancer cell line LNCaP, but not in the highly invasive human prostate cancer cell lines DU-145 and PC-3. Imunohistochemistry studies of human prostate cancer specimens revealed a down-regulation of prostasin in high-grade tumors. Using RT-PCR and western blot analyses, prostasin protein and mRNA expression were found in a non-invasive human breast cancer cell line, MCF-7, while invasive human breast cancer cell lines MDA-MB-231 and MDA-MB-435s were found not to express either the prostasin protein or the mRNA. A non-invasive human breast cancer cell line, MDA-MB-453, was shown to express prostasin mRNA but not prostasin protein. Transfection of DU-145 and PC-3 cells with a full-length human prostasin cDNA restored prostasin expression and reduced the in vitro invasiveness by 68% and 42%, respectively. Transfection of MDA-MB-231 and MDA-MB-435s cells with a full-length human prostasin cDNA restored prostasin expression and reduced the in vitro invasiveness by 50% for either cell line.
    • 已经发现前列腺素蛋白是用于测定人类癌的侵袭性和作为手段治疗人类癌症的有用标志物。 使用RT-PCR和蛋白质印迹分析,在正常人前列腺上皮细胞和人前列腺癌细胞系LNCaP中发现前列腺素蛋白和mRNA表达,但不存在于高侵袭性人前列腺癌细胞系DU-145和PC-3中。 人类前列腺癌标本的免疫组织化学研究显示高级肿瘤中前列腺素的下调。 使用RT-PCR和蛋白质印迹分析,在非侵入性人乳腺癌细胞系MCF-7中发现前列腺素蛋白和mRNA表达,而侵袭性人乳腺癌细胞系MDA-MB-231和MDA-MB-435s分别为 发现不表达前列腺素蛋白或mRNA。 非侵入性人乳腺癌细胞系MDA-MB-453显示表达前列腺素mRNA而不是前列腺素蛋白。 DU-145和PC-3细胞用全长人前列腺素cDNA的转染能够恢复前列腺素的表达,体外侵袭能力分别降低了68%和42%。 用全长人前列腺素cDNA转染MDA-MB-231和MDA-MB-435s细胞恢复前列腺素的表达,并将任何细胞系的体外侵袭力降低50%。
    • 2. 发明授权
    • Method of identifying and treating invasive carcinomas
    • 识别和治疗侵袭性癌的方法
    • US06706483B1
    • 2004-03-16
    • US10368750
    • 2003-02-18
    • Karl X. ChaiLi-Mei ChenLee ChaoJulie Chao
    • Karl X. ChaiLi-Mei ChenLee ChaoJulie Chao
    • C12Q168
    • G01N33/574C12Q1/6886C12Q2600/154C12Q2600/158
    • Prostasin protein has been found to be a useful marker for determination of the invasiveness of and as a means to treat human carcinomas. Using RT-PCR and western blot analyses, prostasin protein and mRNA expression were found in normal human prostate epithelial cells and the human prostate cancer cell line LNCaP, but not in the highly invasive human prostate cancer cell lines DU-145 and PC-3. Imunohistochemistry studies of human prostate cancer specimens revealed a down-regulation of prostasin in high-grade tumors. Using RT-PCR and western blot analyses, prostasin protein and mRNA expression were found in a non-invasive human breast cancer cell line, MCF-7, while invasive human breast cancer cell lines MDA-MB-231 and MDA-MB-435s were found not to express either the prostasin protein or the mRNA. A non-invasive human breast cancer cell line. MDA-MB-453, was shown to express prostasin mRNA but not prostasin protein. Transfection of DU-145 and PC-3 cells with a full-length human prostasin cDNA restored prostasin expression and reduced the in vitro invasiveness by 68% and 42%, respectively. Transfection of MDA-MB-231 and MDA-MB-435s cells with a full-length human prostasin cDNA restored prostasin expression and reduced the in vitro invasiveness by 50% for either cell line.
    • 已经发现前列腺素蛋白是用于测定人类癌的侵袭性和作为手段治疗人类癌症的有用标志物。 使用RT-PCR和蛋白质印迹分析,在正常人前列腺上皮细胞和人前列腺癌细胞系LNCaP中发现前列腺素蛋白和mRNA表达,但不存在于高侵袭性人前列腺癌细胞系DU-145和PC-3中。 人类前列腺癌标本的免疫组织化学研究显示高级肿瘤中前列腺素的下调。 使用RT-PCR和蛋白质印迹分析,在非侵入性人乳腺癌细胞系MCF-7中发现前列腺素蛋白和mRNA表达,而侵袭性人乳腺癌细胞系MDA-MB-231和MDA-MB-435s分别为 发现不表达前列腺素蛋白或mRNA。 非侵入性人乳腺癌细胞系。 MDA-MB-453显示表达前列腺素mRNA而不是前列腺素蛋白。 DU-145和PC-3细胞用全长人前列腺素cDNA的转染能够恢复前列腺素的表达,体外侵袭能力分别降低了68%和42%。 用全长人前列腺素cDNA转染MDA-MB-231和MDA-MB-435s细胞恢复前列腺素的表达,并将任何细胞系的体外侵袭力降低50%。
    • 4. 发明授权
    • Method of identifying and treating invasive carcinomas
    • 识别和治疗侵袭性癌的方法
    • US06864093B1
    • 2005-03-08
    • US10235255
    • 2002-09-05
    • Karl X. ChaiLi-Mei ChenLee ChaoJulie Chao
    • Karl X. ChaiLi-Mei ChenLee ChaoJulie Chao
    • C12Q1/68G01N33/574G01N33/48A61K49/00C07H21/02C07H21/04
    • G01N33/574C12Q1/6886C12Q2600/154C12Q2600/158
    • Prostasin protein has been found to be a useful marker for determination of the invasiveness of and as a means to treat human carcinomas. Using RT-PCR and western blot analyses, prostasin protein and mRNA expression were found in normal human prostate epithelial cells and the human prostate cancer cell line LNCaP, but not in the highly invasive human prostate cancer cell lines DU-145 and PC-3. Imunohistochemistry studies of human prostate cancer specimens revealed a down-regulation of prostasin in high-grade tumors. Using RT-PCR and western blot analyses, prostasin protein and mRNA expression were found in a non-invasive human breast cancer cell line, MCF-7, while invasive human breast cancer cell lines MDA-MB-231 and MDA-MB-435s were found not to express either the prostasin protein or the mRNA. A non-invasive human breast cancer cell line, MDA-MB-453, was shown to express prostasin mRNA but not prostasin protein. Transfection of DU-145 and PC-3 cells with a full-length human prostasin cDNA restored prostasin expression and reduced the in vitro invasiveness by 68% and 42%, respectively. Transfection of MDA-MB-231 and MDA-MB-435s cells with a full-length human prostasin cDNA restored prostasin expression and reduced the in vitro invasiveness by 50% for either cell line. The prostasin gene promoter region was found to be hypermethylated at specific sites in invasive cancer cells.
    • 已经发现前列腺素蛋白是用于测定人类癌的侵袭性和作为手段治疗人类癌症的有用标志物。 使用RT-PCR和蛋白质印迹分析,在正常人前列腺上皮细胞和人前列腺癌细胞系LNCaP中发现前列腺素蛋白和mRNA表达,但不存在于高侵袭性人前列腺癌细胞系DU-145和PC-3中。 人类前列腺癌标本的免疫组织化学研究显示高级肿瘤中前列腺素的下调。 使用RT-PCR和蛋白质印迹分析,在非侵入性人乳腺癌细胞系MCF-7中发现前列腺素蛋白和mRNA表达,而侵袭性人乳腺癌细胞系MDA-MB-231和MDA-MB-435s分别为 发现不表达前列腺素蛋白或mRNA。 非侵入性人乳腺癌细胞系MDA-MB-453显示表达前列腺素mRNA而不是前列腺素蛋白。 DU-145和PC-3细胞用全长人前列腺素cDNA的转染能够恢复前列腺素的表达,体外侵袭能力分别降低了68%和42%。 用全长人前列腺素cDNA转染MDA-MB-231和MDA-MB-435s细胞恢复前列腺素的表达,并将任何细胞系的体外侵袭力降低50%。 发现前列腺素基因启动子区域在侵袭性癌细胞的特定部位被高甲基化。
    • 5. 发明授权
    • Method of identifying and treating invasive carcinomas
    • 识别和治疗侵袭性癌的方法
    • US06569684B2
    • 2003-05-27
    • US09755811
    • 2001-01-05
    • Karl X. ChaiLi-Mei ChenLee ChaoJulie Chao
    • Karl X. ChaiLi-Mei ChenLee ChaoJulie Chao
    • G01N3348
    • G01N33/574C12Q1/6886C12Q2600/154C12Q2600/158
    • Prostasin protein has been found to be a useful marker for determination of the invasiveness of and as a means to treat human carcinomas. Using RT-PCR and western blot analyses, prostasin protein and mRNA expression were found in normal human prostate epithelial cells and the human prostate cancer cell line LNCaP, but not in the highly invasive human prostate cancer cell lines DU-145 and PC-3. Imunohistochemistry studies of human prostate cancer specimens revealed a down-regulation of prostasin in high-grade tumors. Using RT-PCR and western blot analyses, prostasin protein and mRNA expression were found in a non-invasive human breast cancer cell line, MCF-7, while invasive human breast cancer cell lines MDA-MB-231 and MDA-MB-435s were found not to express either the prostasin protein or the mRNA. A non-invasive human breast cancer cell line, MDA-MB-453, was shown to express prostasin mRNA but not prostasin protein. Transfection of DU-145 and PC-3 cells with a full-length human prostasin cDNA restored prostasin expression and reduced the in vitro invasiveness by 68% and 42%, respectively. Transfection of MDA-MB-231 and MDA-MB-435s cells with a full-length human prostasin cDNA restored prostasin expression and reduced the in vitro invasiveness by 50% for either cell line.
    • 已经发现前列腺素蛋白是用于测定人类癌的侵袭性和作为手段治疗人类癌症的有用标志物。 使用RT-PCR和蛋白质印迹分析,在正常人前列腺上皮细胞和人前列腺癌细胞系LNCaP中发现前列腺素蛋白和mRNA表达,但不存在于高侵袭性人前列腺癌细胞系DU-145和PC-3中。 人类前列腺癌标本的免疫组织化学研究显示高级肿瘤中前列腺素的下调。 使用RT-PCR和蛋白质印迹分析,在非侵入性人乳腺癌细胞系MCF-7中发现前列腺素蛋白和mRNA表达,而侵袭性人乳腺癌细胞系MDA-MB-231和MDA-MB-435s分别为 发现不表达前列腺素蛋白或mRNA。 非侵入性人乳腺癌细胞系MDA-MB-453显示表达前列腺素mRNA而不是前列腺素蛋白。 DU-145和PC-3细胞用全长人前列腺素cDNA的转染能够恢复前列腺素的表达,体外侵袭能力分别降低了68%和42%。 用全长人前列腺素cDNA转染MDA-MB-231和MDA-MB-435s细胞恢复前列腺素的表达,并将任何细胞系的体外侵袭力降低50%。
    • 7. 发明授权
    • System and method for calibrating an ambient light sensor
    • 用于校准环境光传感器的系统和方法
    • US08481917B2
    • 2013-07-09
    • US12612012
    • 2009-11-04
    • Li-Mei ChenMing-Fu ChenYi-Hsun Lin
    • Li-Mei ChenMing-Fu ChenYi-Hsun Lin
    • G01D18/00G01J5/00G06F5/02
    • G01J1/42G01J1/4204G01J1/44G09G2320/062
    • A system and a method for calibrating an ambient light sensor (ALS) are disclosed. The ALS, an adjustable resistor and a switch are located on a first surface of a printed circuit board (PCB), and the adjustable resistor and the switch are connected in series between an adjustable probe of the ALS and the ground. A resistor is connected between two pads located on a second surface of the PCB via two probes touching the pads. A controller connected to the PCB reads a light sensitivity of the ALS and calculates a calculated resistance value of the adjustable resistor by a formula “detected light sensitivity/resistance value of the resistor=objective light sensitivity/resistance value of the adjustable resistor”, wherein the objective light sensitivity and the resistance value of the resistor are given.
    • 公开了一种用于校准环境光传感器(ALS)的系统和方法。 ALS,可调电阻器和开关位于印刷电路板(PCB)的第一表面上,可调电阻器和开关串联连接在ALS的可调探针和地之间。 电阻器通过两个接触焊盘的探头连接在位于PCB的第二表面上的两个焊盘之间。 连接到PCB的控制器读取ALS的光灵敏度,并通过公式“电阻的检测光敏度/电阻值=可调电阻器的目标光灵敏度/电阻值”来计算可调电阻器的计算电阻值,其中 给出了目标光敏度和电阻值的电阻值。